|
|
Peer-Reviewed Publications
- Lou TZ, Williams A, Li W, Pace BS. The role of nitric oxide in gamma-globin induction by hydroxyurea. Exp Biol. in press
- Xiao Y, Kodeboyina S, Liu L, Dzandu J, Sangerman J, Ofori-Acquah S, Pace BS. Stat3/GATA-1 interaction in the g-Globin 5’UTR modulates fetal hemoglobin. Exp Hematol. in press
- Hassell K, Pace BS, Wang W, Kulkarni R, Luban N, Johnson C, Eckman J, Lane P, Woods W. Sickle Cell Disease Summit: From Clinical and Research Disparity to Action. Am J Hematol. 84:39-45, 2009.
- Liu L, Muralidhar S, Singh M, Sylvan C, Kalra I, Quinn C, Onyekwere OC, Pace BS. High Density SNP-Chip Genotyping and Haploview Analysis to Define b-Globin Locus Haplotypes. Blood Cell Mol Dis. 42:16-24, 2009.
- Pace BS and Zein S. Understanding Mechanisms of g-Globin Gene Regulation to Develop Strategies for Pharmacological Fetal Hemoglobin Induction. Dev Dyn. 235:1727-37, 2007.
- Renaissance of Sickle Cell Disease Research in the Genomic Era, Editor: Betty S. Pace, Imperial Press, London England, First Edition 2007.
- Sangerman J, Lee MS, Yao X, Oteng E, Hsiao CH, Li W, Zein S, Ofori-Acquah SF, Pace BS. Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2. Blood. 108:3590-9, 2006.
- Hsiao CH, Li W, Lou TF, Baliga BS, Pace BS. Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. Exp Hematol. 34:264-73, 2006.
- Pace BS, Zein S. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction. Dev Dyn. 235:1727-37, 2006.
- McElveen RL, Lou TF, Reese K, Xia S, Baliga BS, Pace BS. Erk pathway inhibitor U0126 induces gamma-globin expression in erythroid cells. Cell Mol Biol. 51:215-27, 2005.
|
|
